Covered recipient · General Payments record
AMREET K AUJLA
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2021–2024
$4,631.31
- Reported across 171 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $692.92 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $434.85 | 23 |
| Lilly USA, LLC | $74.13 | 3 |
| Madrigal Pharmaceuticals | $33.33 | 2 |
| Exact Sciences Corporation | $28.37 | 1 |
| Medtronic, Inc. | $27.01 | 1 |
| Ardelyx, Inc. | $23.42 | 1 |
| QOL Medical, LLC | $21.60 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $17.50 | 1 |
| Phathom Pharmaceuticals, Inc. | $17.00 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.26 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251901 | CMS |
| ABBVIE INC. | $20.14 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251903 | CMS |
| ABBVIE INC. | $22.96 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251905 | CMS |
| ABBVIE INC. | $17.75 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251907 | CMS |
| ABBVIE INC. | $125.00 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251909 | CMS |
| ABBVIE INC. | $11.07 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251911 | CMS |
| ABBVIE INC. | $14.33 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251913 | CMS |
| ABBVIE INC. | $1.68 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251915 | CMS |
| ABBVIE INC. | $24.15 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251917 | CMS |
| ABBVIE INC. | $19.97 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251919 | CMS |
| ABBVIE INC. | $18.26 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251921 | CMS |
| ABBVIE INC. | $1.27 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251923 | CMS |
| ABBVIE INC. | $11.31 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251925 | CMS |
| ABBVIE INC. | $0.57 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251927 | CMS |
| ABBVIE INC. | $11.25 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251929 | CMS |
| ABBVIE INC. | $26.17 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251931 | CMS |
| ABBVIE INC. | $30.32 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251933 | CMS |
| ABBVIE INC. | $21.78 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251935 | CMS |
| ABBVIE INC. | $0.29 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251937 | CMS |
| ABBVIE INC. | $7.92 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251939 | CMS |
| ABBVIE INC. | $13.73 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251941 | CMS |
| ABBVIE INC. | $7.04 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251943 | CMS |
| ABBVIE INC. | $10.63 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103251945 | CMS |
| Ardelyx, Inc. | $23.42 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146669809 | CMS |
| Exact Sciences Corporation | $28.37 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114481151 | CMS |
| Intercept Pharmaceuticals, Inc. | $17.50 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113630422 | CMS |
| Lilly USA, LLC | $22.06 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136036010 | CMS |
| Lilly USA, LLC | $25.86 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136027996 | CMS |
| Lilly USA, LLC | $26.21 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136031308 | CMS |
| Madrigal Pharmaceuticals | $17.51 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144160795 | CMS |
| Madrigal Pharmaceuticals | $15.82 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144160797 | CMS |
| Medtronic, Inc. | $27.01 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117037337 | CMS |
| Phathom Pharmaceuticals, Inc. | $17.00 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151036797 | CMS |
| QOL Medical, LLC | $21.60 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147713100 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.71 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153558427 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.